Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp.verified

PHIOW

Price:

$0.0232

Market Cap:

$11.63M

Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zent...[Read more]

Industry

Biotechnology

IPO Date

2022-01-31

Stock Exchange

NASDAQ

Ticker

PHIOW

The Enterprise Value as of December 2025 (TTM) for Phio Pharmaceuticals Corp. (PHIOW) is 920.58K

According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 920.58K. This represents a change of -96.95% compared to the average of 30.23M of the last 4 quarters.

Phio Pharmaceuticals Corp. (PHIOW) Historical Enterprise Value (quarterly & annually)

How has PHIOW Enterprise Value performed in the past?

The mean historical Enterprise Value of Phio Pharmaceuticals Corp. over the last ten years is -1080955.00. The current 920.58K Enterprise Value has changed -8616.38% with respect to the historical average. Over the past ten years (40 quarters), PHIOW's Enterprise Value was at its highest in in the September 2025 quarter at 124.92M. The Enterprise Value was at its lowest in in the March 2025 quarter at -13277944.01.

Quarterly (TTM)
Annual

Average

-1080955.00

Median

-4314220.60

Minimum

-12559619.32

Maximum

19.82M

Phio Pharmaceuticals Corp. (PHIOW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Phio Pharmaceuticals Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 758.60%

Maximum Annual Enterprise Value = 19.82M

Minimum Annual Increase = -240.30%

Minimum Annual Enterprise Value = -12559619.32

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20248.79M-227.89%
2023-6874960.005.09%
2022-6541931.38-40.22%
2021-10944128.00758.60%
2020-1274655.36-38.91%
2019-2086509.82-83.39%
2018-12559619.32-240.30%
20178.95M-210.65%
2016-8090026.35-140.82%
201519.82M-25.59%

Phio Pharmaceuticals Corp. (PHIOW) Average Enterprise Value

How has PHIOW Enterprise Value performed in the past?

The current Enterprise Value of Phio Pharmaceuticals Corp. (PHIOW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1541501.13

5-year avg

-3368657.35

10-year avg

-1080955.00

Phio Pharmaceuticals Corp. (PHIOW) Enterprise Value vs. Peers

How is PHIOW’s Enterprise Value compared to its peers?

Phio Pharmaceuticals Corp.’s Enterprise Value is less than Ontrak, Inc. (5.59M), less than BiomX Inc. (1.04M), greater than TFF Pharmaceuticals, Inc. (-2265301.00), greater than Biocept, Inc. (-337214.00), less than Peak Bio, Inc. (7.00M), greater than TC Biopharm (Holdings) Plc (-468979.97), greater than GBS Inc. (-304527.00), greater than Virios Therapeutics, Inc. (-13215612498.00), less than LakeShore Biopharma Co., Ltd (631.25M), less than Seelos Therapeutics, Inc. (11.45M),

CompanyEnterprise ValueMarket cap
5.59M$2.34M
1.04M$2.37M
-2265301.00$288.80K
-337214.00$450.79K
7.00M$520.31K
-468979.97$256.50K
-304527.00$433.58K
-13215612498.00$206.50K
631.25M$25.84M
11.45M$214.97K

Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIOW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phio Pharmaceuticals Corp. (PHIOW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Phio Pharmaceuticals Corp.'s Enterprise Value?

What is the highest Enterprise Value for Phio Pharmaceuticals Corp. (PHIOW)?

What is the 3-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIOW)?

What is the 5-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIOW)?

How does the current Enterprise Value for Phio Pharmaceuticals Corp. (PHIOW) compare to its historical average?